|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 35/00 | (2006.01) |
| A61K 38/16 | (2013.01) | ||
| A61K 38/16 | (2006.01) | ||
| A61K 39/3955 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61K2039/545 | (2013.01) | ||
| C07K 16/2818 | (2013.01) |
| (11) | Patento numeris | 3810279 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19734322.1 |
| Europos patento paraiškos padavimo data | 2019-06-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-04-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-09-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2019/066295 |
| Data | 2019-06-19 |
| (87) | Numeris | WO 2019/243471 |
| Data | 2019-12-26 |
| (30) | Numeris | Data | Šalis |
| 201810058 | 2018-06-19 | GB |
| (72) |
PRESTEGARDEN, Lars , NO
|
| (73) |
Cytovation ASA ,
Solheimsgaten 11, 5058 Bergen,
NO
|
| (54) | A COMBINATION COMPRISING USING AN OLIGOPEPTIDIC COMPOUND AND ANTI-PD-1 OR PD-L1 ANTIBODY FOR USE IN TREATING NEOPLASTIC CONDITIONS |
| A COMBINATION COMPRISING USING AN OLIGOPEPTIDIC COMPOUND AND ANTI-PD-1 OR PD-L1 ANTIBODY FOR USE IN TREATING NEOPLASTIC CONDITIONS |